Design Therapeutics, Inc. - Common Stock (DSGN)

Historical Holders from Q1 2021 to Q1 2025

Symbol
DSGN on Nasdaq
CUSIP
25056L103
Type / Class
Equity / Common Stock
Shares outstanding
55.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
33.4M
Holdings value
$206M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
93
Number of buys
46
Number of sells
-39
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Design Therapeutics, Inc. - Common Stock (DSGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Light Irrevocable Trust #1 dated April 22, 2019 6.9% $14.8M 3.83M Light Irrevocable Trust #1 dated April 22, 2019 Dec 31, 2024
Star Irrevocable Trust #1 dated April 22, 2019 6.9% $14.8M 3.83M Star Irrevocable Trust #1 dated April 22, 2019 Dec 31, 2024

Institutional Holders of Design Therapeutics, Inc. - Common Stock (DSGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 96.8K $373K -$107K $3.86 6
2024 Q4 33.4M $206M +$9.37M $6.17 93
2024 Q3 32M $172M +$1.33M $5.38 99
2024 Q2 32.1M $108M +$4.41M $3.35 92
2024 Q1 30.7M $124M -$2.84M $4.03 88
2023 Q4 31.7M $84M -$2.33M $2.65 87
2023 Q3 32.9M $77.6M -$68.5M $2.36 84
2023 Q2 38.8M $244M +$735K $6.30 96
2023 Q1 38.7M $223M -$16.1M $5.77 97
2022 Q4 40.4M $414M -$490K $10.26 80
2022 Q3 39.9M $667M +$24.3M $16.72 76
2022 Q2 38.5M $540M +$8.62M $14.00 67
2022 Q1 32.4M $523M +$27.8M $16.15 60
2021 Q4 30.5M $653M +$50.2M $21.41 56
2021 Q3 28.3M $415M +$5.45M $14.69 52
2021 Q2 27.8M $546M +$37.4M $19.89 48
2021 Q1 25.8M $755M +$755M $29.90 43